Finished CBD Product Sample KitDecember 16, 2022
Amanita Muscaria Mushroom ExtractJanuary 16, 2023
Wholesale CBDV Isolate
About our CBDV Isolate
Cannabidivarin, also known as CBDV, is a non-intoxicating rare cannabinoid that was first isolated in 1969. CBDV is one of the more than 140 rare cannabinoids, also referred to as minor cannabinoids, found in the Cannabis sativa plant. Although research into rare cannabinoids is at a nascent stage, CBDV is one of the most studied rare cannabinoids in a myriad of conditions.
Crystalline CBDV isolate is available for B2B wholesale online purchasing as a raw ingredient for a variety of consumer health and wellness products, such as cosmetics, nutraceuticals, supplements and animal health.
Online ordering options are 4 gram samples, 10 grams, 25 grams, 50 grams, 100 grams, 250 grams, 500 grams and 1 kilogram.
More information about CBDV Isolate
CBDV, or cannabidivarin, is a naturally occurring compound found in cannabis plants. As one of the many cannabinoids present in cannabis, CBDV has gained attention for its potential therapeutic properties.
Cannabinoids are chemical compounds that interact with the endocannabinoid system in the body. The endocannabinoid system is a complex cell-signaling system that plays a role in regulating various physiological processes, including mood, pain, inflammation, appetite, and immune function. CBDV is structurally similar to another well-known cannabinoid, cannabidiol (CBD), but has some differences in its molecular composition.
One of the key features of CBDV is that it is non-intoxicating, meaning it does not produce the psychoactive effects typically associated with cannabis use. This has made CBDV an attractive option for potential medical use, as it may offer therapeutic benefits without the psychoactive side effects.
Research on CBDV is still in its early stages, but there is growing evidence to suggest that it may have potential therapeutic applications. One area of research that has garnered significant interest is the potential anti-epileptic properties of CBDV isolate. Several studies have shown that CBDV may be effective in reducing seizure frequency and severity in animal models of epilepsy. For example, a study published in the British Journal of Pharmacology found that CBDV was able to reduce both the frequency and severity of seizures in a mouse model of epilepsy. Another study published in the journal Neuropharmacology showed that CBDV was effective in reducing seizures in a rat model of epilepsy.
These promising results have led to further research and clinical trials to investigate the use of CBDV as a potential treatment for epilepsy and other neurological conditions in humans. While more research is needed to fully understand the mechanisms underlying CBDV’s anti-epileptic effects and to determine its safety and efficacy in humans, the early findings are encouraging and suggest that CBDV may hold promise as a potential therapeutic option for epilepsy patients.
In addition to its potential anti-epileptic properties, bulk CBDV isolate has also been studied for its potential anti-inflammatory effects. Inflammation is a natural response by the body to injury or infection, but chronic inflammation can contribute to various health conditions, including autoimmune diseases, neurodegenerative diseases, and gastrointestinal disorders. Some research has suggested that CBDV may have anti-inflammatory properties, which could make it a potential therapeutic option for managing inflammation-related conditions.
Wholesale CBDV isolate has also been investigated for its potential anti-nausea effects. Nausea and vomiting are common symptoms associated with various medical conditions, such as chemotherapy-induced nausea and vomiting, morning sickness during pregnancy, and motion sickness. Some research has suggested that CBDV may be effective in reducing nausea and vomiting, although the mechanisms underlying these effects are not fully understood and further research is needed.
Furthermore, CBDV has been studied for its potential anti-anxiety effects. Anxiety disorders are a prevalent mental health condition, and many individuals seek alternative treatments for anxiety beyond traditional pharmaceuticals. Some research has suggested that CBDV may have anxiolytic properties, meaning it may help reduce anxiety symptoms. However, more research is needed to fully understand the effects of CBDV on anxiety and to determine its safety and efficacy for this purpose.
It’s important to note that while CBDV shows promise in preclinical and early clinical research, more robust and comprehensive studies are needed to fully understand its potential therapeutic uses, optimal dosages, and long-term safety. As with any cannabinoid or cannabis-derived compound, it’s essential to consult with a qualified healthcare professional before using CBDV or CBDV-containing products, especially if you have any underlying health conditions or are taking medications that may interact with CBDV.
In conclusion, CBDV is a cannabinoid found in cannabis plants that has gained attention for its potential therapeutic properties